1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Ireland Neurodiagnostics Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Ireland Neurodiagnostics Market
4. Ireland Neurodiagnostics Market by
Technology Type
4.1. Neuroimaging
4.1.1. Nuclear Medicine Imaging
4.1.2. Electro-encephalography
4.1.3. Magneto-encephalography
4.1.4. Other Neuroimaging Technologies
4.2. in Vitro Diagnosis
4.2.1. Genetic Testing
4.2.2. Protein Biomarker Assay
4.2.3. Other in Vitro Diagnosis
4.3. Neuroinformatics
5. Ireland Neurodiagnostics Market by
Disease Type
5.1. Migraine
5.2. Multiple Sclerosis
5.3. Alzheimer’s Disease
5.4. Parkinson’s Disease
5.5. Depression
5.6. Other Diseases
6. Ireland Neurodiagnostics Market by
End-user
6.1. Neurology Centers
6.2. Diagnostic Laboratories and Imaging Centers
6.3. Hospitals and Surgical Centers
6.4. Ambulatory Care Centers
6.5. Research Laboratories
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Ireland Neurodiagnostics Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Ireland Neurodiagnostics Market
4. Ireland Neurodiagnostics Market by
Technology Type
4.1. Neuroimaging
4.1.1. Nuclear Medicine Imaging
4.1.2. Electro-encephalography
4.1.3. Magneto-encephalography
4.1.4. Other Neuroimaging Technologies
4.2. in Vitro Diagnosis
4.2.1. Genetic Testing
4.2.2. Protein Biomarker Assay
4.2.3. Other in Vitro Diagnosis
4.3. Neuroinformatics
5. Ireland Neurodiagnostics Market by
Disease Type
5.1. Migraine
5.2. Multiple Sclerosis
5.3. Alzheimer’s Disease
5.4. Parkinson’s Disease
5.5. Depression
5.6. Other Diseases
6. Ireland Neurodiagnostics Market by
End-user
6.1. Neurology Centers
6.2. Diagnostic Laboratories and Imaging Centers
6.3. Hospitals and Surgical Centers
6.4. Ambulatory Care Centers
6.5. Research Laboratories
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5